Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis.

Chang Chu Xin ChenAhmed A HasanAngelika SzakallovaBernhard K KrämerMartin TepelBerthold Hocher

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)

Ang-2 at baseline is independently associated with all-cause mortality in male ESRD patients on HD.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
angiotensin ii